Jade Biosciences, Inc. (JBIO)

Jade Biosciences Statistics

Total Valuation

JBIO has a market cap or net worth of $826.54 million. The enterprise value is $491.23 million.

Market Cap	826.54M
Enterprise Value	491.23M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

JBIO has 49.32 million shares outstanding.

Current Share Class	49.32M
Shares Outstanding	49.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+36.39%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	78.73%
Float	32.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.49
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.09, with a Debt / Equity ratio of 0.00.

Current Ratio	21.09
Quick Ratio	20.33
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.54

Financial Efficiency

Return on equity (ROE) is -89.18% and return on invested capital (ROIC) is -36.01%.

Return on Equity (ROE)	-89.18%
Return on Assets (ROA)	-33.59%
Return on Invested Capital (ROIC)	-36.01%
Return on Capital Employed (ROCE)	-34.07%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.82M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, JBIO has paid $58,000 in taxes.

Income Tax	58,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	14.64
200-Day Moving Average	11.49
Relative Strength Index (RSI)	67.21
Average Volume (20 Days)	597,077

Short Selling Information

The latest short interest is 1.53 million, so 3.11% of the outstanding shares have been sold short.

Short Interest	1.53M
Short Previous Month	1.56M
Short % of Shares Out	3.11%
Short % of Float	4.73%
Short Ratio (days to cover)	5.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.54M
Pretax Income	-127.35M
Net Income	-100.14M
EBITDA	-113.52M
EBIT	-113.54M
Earnings Per Share (EPS)	-$3.19

Balance Sheet

The company has $336.16 million in cash and $851,000 in debt, with a net cash position of $335.31 million or $6.80 per share.

Cash & Cash Equivalents	336.16M
Total Debt	851,000
Net Cash	335.31M
Net Cash Per Share	$6.80
Equity (Book Value)	332.52M
Book Value Per Share	6.74
Working Capital	332.28M

Cash Flow

In the last 12 months, operating cash flow was -$94.69 million and capital expenditures -$196,000, giving a free cash flow of -$94.89 million.

Operating Cash Flow	-94.69M
Capital Expenditures	-196,000
Depreciation & Amortization	26,000
Net Borrowing	n/a
Free Cash Flow	-94.89M
FCF Per Share	-$1.92

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.12%
FCF Yield	-11.48%

Analyst Forecast

The average price target for JBIO is $29.20, which is 74.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.20
Price Target Difference	74.22%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1